Yearly Archives: 2018


Original article:  http://www.psychiatrictimes.com/psychotherapy/best-and-not-so-great-articles-2017  By Jerald Kay. MD. December 2017 issue of the Psychiatric Times. A few points regarding the articles presented: 1.    On the Roy-Berne et al. article on “highlighting the myth of precision psychiatry”. I think Dr Kay and others need to have a long-term perspective. While genetic testing is a […]

Douglas Berger, Tokyo Psychiatrist comments on, “The Best and Not ...


Douglas Berger, Psychiatrist in Tokyo comments on, “Sex Addiction: Playing Now in Theaters”, By Roberta Zanzonico, MD and Renee M. Sorrentino, MD, Psychiatric Times, January 2018. Original Article: http://www.psychiatrictimes.com/article/sex-addiction-playing-now-theaters This article seems mired in needless philosophic details about how to care for this 85 year-old man with vascular dementia admitted […]

Douglas Berger, Psychiatrist in Tokyo comments on, “Sex Addiction: Playing ...


Link to Article:  Innovative Strategies for Addressing Substance Use Disorders: The Classic Hallucinogens Dr Bogenshultz describes this study: Residential psychedelic (LSD) therapy for the narcotic addict. Savage C, McCabe OL. A controlled study. Arch Gen Psychiatry. 1973 Jun;28(6):808-14. Bogenshultz is taking the value of the results too far without looking […]

Doug Berger psychiatrist in Tokyo comments on: “Innovative Strategies for ...



Psychiatric Times, April 29, 2017 By Lauren M. Osborne, MD, Katherine McEvoy, MB ChB, and Jennifer L. Payne, MD Original Article’s URL: http://www.psychiatrictimes.com/special-reports/antidepressants-pregnancy-balancing-needs-and-risks-clinical-practice Dear authors, you mention that psychotherapy, yoga, acupuncture are “evidence-based nonpharmacological treatments” for mood disorders during pregnancy. I wonder if you can reference any study of these 3 […]

Doug Berger, psychiatrist in Tokyo comments on: “Antidepressants in Pregnancy: ...



Social Media https://www.facebook.com/douglas.berger.3954 https://twitter.com/Douglas_Berger1 https://www.linkedin.com/in/douglasbergerpsychiatristtokyo/ Blogs: https://www.youtube.com/channel/UCDj351WhGaBdU22UeV1NCCw https://douglasbergerpsychiatristtokyo.tumblr.com/ https://douglasbergerpsychiatristtokyoblog.wordpress.com/ http://douglasbergerpsychiatristtokyo.weebly.com/ Websites: DouglasBergerPsychiatristTokyo.com http://douglas-berger-psychiatrist-tokyo-reviews.com/ http://about-douglas-berger-psychiatrist-tokyo.com/ http://douglas-berger-psychiatrist-tokyo-info.com/ https://douglas-berger-psychiatrist-tokyo.com/

Please Follow Me On My Social Media, Blogs, and Websites:




The open-label GeneSight and unblined Genomind studies are at high-risk for researcher bias and should be suspect to extreme caution. We would never allow anti-depressants to be approved with these kinds of studies (although unblinded/no-blindplacebo psychotherapy studies are unreasonably and widely “accepted” as robust data by our profession all the […]

Comment by Douglas Berger Psychiatrist in Japan on: Weighing the ...